Skip to content

FP7H2020

Cancer Research UK Lbg

Country
GBUnited Kingdom
Defence projects
0
Projects, all programmes
80
As coordinator
36
EU contribution (CORDIS)
EUR 16,198,905
Active
2008 to 2017

Projects

80 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
ATMINDDRATMINistrating ATM signalling: exploring the significance of ATM regulation by ATMINFP72012ParticipantNot stated
MEIOTIC CENTROMERESFunction of centromeres during meiotic bouquet stage and protein composition of telomeresFP72012CoordinatorEUR 182,103
Melanoma GenesGene Discovery in Melanoma Progression and Therapeutic ResistanceFP72012ParticipantNot stated
Cancer metastasisIdentification of important regulators of metastasis in pancreatic cancerFP72012CoordinatorEUR 200,372
HIVINNOVGeneration of a new class of antiretrovirals targeting HIV-cellular cofactors interactionsFP72012ParticipantEUR 288,692
DCSUBSETCross-species characterisation of CD8alpha+ dendritic cells and their role in immune regulationFP72011ParticipantNot stated
TRANSINTEGTranscription and the maintenance of genome integrityFP72011ParticipantNot stated
ACTINONSRFMAL: an actin-regulated SRF transcriptional coactivatorFP72011ParticipantNot stated
WNT VASCULAR REMODELMolecular control of vascular remodelling: A role for Wnt signalling.FP72011CoordinatorEUR 173,241
MICROTUBULE PLUS ENDStructural and kinetic basis of evolutionary conserved and divergent microtubule plus end tracking mechanismsFP72011CoordinatorEUR 172,241
RITTARRGS1 in intestinal T cell trafficking and responsivenessFP72011CoordinatorEUR 209,093
RETROGRADE TRANSPORTThe role of Rab7 in axonal retrograde transport and human pathologiesFP72011CoordinatorEUR 173,241
RIG‐I Live ImagingImaging influenza nucleic acid recognition by RIG-I in living cellsFP72011CoordinatorEUR 200,050
QUIC-CONCEPTQUantitative Imaging in Cancer: CONnecting CEllular Processes with TherapyFP72011ParticipantEUR 88,511
PREDICTPredicting individual response and resistance to VEGFR/mTOR pathway therapeutic intervention using biomarkers discovered through tumour functional genomicsFP72011ParticipantEUR 1,483,296
LUNGTARGETNew approaches for the targeted therapy of Non-Small Cell Lung CancerFP72011ParticipantEUR 379,055
EPC-TM-NETTargeting the tumour microenvironment to improve pancreatic cancer prognosisFP72011ParticipantEUR 144,365
TRANSCANERA-NET on Translational Cancer ResearchFP72011ParticipantEUR 111,012
CHROMALC1HCC“The role of ALC1, a novel ATP-dependent chromatin remodelling protein, in transcriptional regulation, tumorigenesis and neurodegeneration”FP72011CoordinatorEUR 172,741
RECMITMEIRegulating recombination in mitotic and meiotic cellsFP72011ParticipantNot stated

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.